Newsletter Tool

To view this email as a web page, click here

Today's Rundown

AstraZeneca's COVID-19 antibody combination fails post-exposure prevention trial
Two shots of Pfizer, AstraZeneca COVID-19 vaccines effective against Delta variant: study
He authorized Moderna's vaccine 6 months ago. Now, ex-FDA chief Hahn joins biotech's backer
More physicians have become millionaires since before the pandemic, survey finds
COVID-19 tracker: Novavax shot remains effective alongside flu jab; NIH study finds evidence of late 2019 infections
UPDATED Coronavirus tracker: Assisted living residents' all-cause mortality increased 17% as COVID-19 spread through US

Featured Story

AstraZeneca's COVID-19 antibody combination fails post-exposure prevention trial

By Nick Paul Taylor

AstraZeneca’s anti-SARS-CoV-2 antibody combination has failed a phase 3 clinical trial designed to assess its ability to prevent symptomatic COVID-19 in people recently exposed to the pandemic coronavirus. However, while the study missed its primary endpoint, a subgroup analysis of people who were PCR-negative at baseline offered encouragement to AstraZeneca.

Two shots of Pfizer, AstraZeneca COVID-19 vaccines effective against Delta variant: study

By Kevin Dunleavy

In a real-world study in the U.K., two shots of the Pfizer or AstraZeneca COVID-19 vaccine were effective in preventing hospitalizations caused by the Delta variant, which scientists first detected in India.

He authorized Moderna's vaccine 6 months ago. Now, ex-FDA chief Hahn joins biotech's backer

By Kyle LaHucik

Ex-FDA Commissioner Stephen Hahn, M.D., is joining Moderna incubator Flagship Pioneering six months after granting the company an emergency use authorization for its COVID-19 vaccine.

More physicians have become millionaires since before the pandemic, survey finds

By Dave Muoio

A poll of nearly 18,000 U.S. physicians suggests home ownership and other pre-pandemic investments helped many doctors break seven figures during a volatile year.

COVID-19 tracker: Novavax shot remains effective alongside flu jab; NIH study finds evidence of late 2019 infections

By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner

Novavax said its COVID-19 shot remained highly effective when administered alongside an already-approved influenza vaccine. A new government study found evidence of COVID-19 infections in the U.S. as early as December 2019. And more headlines.

UPDATED Coronavirus tracker: Assisted living residents' all-cause mortality increased 17% as COVID-19 spread through US

By Healthcare Staff

Follow along with the latest COVID-19 news straight from the Fierce Healthcare team.

COVID-19 Tracker